Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - AMERICAN CRYOSTEM CorpFinancial_Report.xls

 



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Amendment No. 1 To

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2012

 

Commission file number: 000-54672

 

AMERICAN CRYOSTEM CORPORATION

 

(Name of registrant as specified in its charter)

 

Nevada   26-4574088
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)

 

1 Meridian Road, Eatontown, NJ 07724

(Address of principal executive offices)(Zip Code)

 

(732) 747-1007

 

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes S No £

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes S No £ 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer £ Accelerated filer £

Non-accelerated filer £

(Do not check if smaller reporting company)

Smaller reporting company S

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)

Yes £ No S

 

As of August 28, 2012, there were 29,949,362 shares of common stock outstanding.

 

 
 

 

EXPLANATORY NOTE

 

The sole purpose of this Amendment No. 1 to American CryoStem Corporation’s Quarterly Report on Form 10-Q (the “Form 10-Q”) for the period ended June 30, 2012, as filed with the Securities and Exchange Commission on August 20, 2012, is to furnish Exhibit 101 to the Form 10-Q in accordance with Rule 405 of Regulation S-T. Exhibit 101 provides the financial statements and related notes from the Form 10-Q formatted in XBRL (eXtensible Business Reporting Language).

 

No other changes have been made to the Form 10-Q. This Amendment No. 1 to the Form 10-Q does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way disclosures made in the original Form 10-Q.

 

PART II - OTHER INFORMATION

 

ITEM 6. EXHIBITS

 

Exhibit No. Description
   
(a) Documents furnished as Exhibits hereto:
   
101. INS XBRL Instance Document (2)
101. SCH XBRL Taxonomy Extension Schema Document (2)
101. CAL XBRL Taxonomy Extension Calculation Linkbase Document (2)
101. DEF XBRL Taxonomy Extension Definition Linkbase Document (2)
101. LAB XBRL Taxonomy Extension Label Linkbase Document (2)
101. PRE XBRL Taxonomy Extension Presentation Linkbase Document (2)

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  AMERICAN CRYOSTEM CORPORATION
     
September 6, 2012 By: /s/ John Arnone
    John Arnone, Chief Executive Officer
    (Principal Executive Officer)
     
September 6, 2012 By: /s/ Anthony Dudzinski
    Anthony Dudzinski, Treasurer
    (Principal Financial Officer)